Developing the Next Generation of Immunotherapeutic Strategies for Solid Tumors
Release Date: June 24, 2009|
Expiration Date: June 24, 2010
May 30, 2009, Orlando, FL
This on-demand Webcast is from a satellite symposium held in conjunction with the 45th Annual Meeting of the American Society of Clinical Oncology held on May 29-June 2, 2009, in Orlando, FL.
The Developing the Next Generation of Immunotherapeutic Strategies for Solid Tumors symposium is designed to provide participants with cutting-edge information on the development of cancer immunotherapy. Harnessing the specificity of the patient’s immune system, vaccines, and immunotherapies are potentially the ultimate targeted agents, and this program will review the immunobiology of cancer vaccines and the refinement of approaches to optimize the activity of vaccines. Internationally recognized experts will review vaccines and immunotherapeutic agents in development for lung cancer, melanoma, and prostate cancer. An expert panel discussion will address key questions to improve clinical investigation of therapeutic cancer vaccines. This program will conclude with a look at late-breaking and upcoming clinical data on immunotherapy for patients with cancer.
This educational activity is directed toward medical oncologists involved in the care of patients with solid tumors. Fellows, nurses, physician assistants, and pharmacists are also invited to participate.
Upon completion of this educational activity, you should be able to:
You will be permitted 2 attempts to successfully complete the Posttest.